SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. for SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislative proposals that would incrase the Medicaid drug price rebate. (none yet introduced in this Congress)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
| ANGELA M STEWART | — |
Copyright/Patent/Trademark CPT
H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Health Issues HCR
H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Labor Issues/Antitrust/Workplace LBR
H.R.2, Children's Health Insurance Program Reauthorization Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Taxation/Internal Revenue Code TAX
S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.
| Lobbyist | Covered position, as disclosed |
|---|---|
| G LAWRENCE ATKINS | — |
| PAUL EHRLICH | — |
| ROBERT W LIVELY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.